Viewing Expert Gordon Reid | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Viewing Expert

Gordon Reid , President

GoodReid Investment Counsel

Address
47 Colborne Street
Suite 400
Toronto, ON
M5E 1P8

Contact Info
Telephone: 416.364.0890
Toll Free: 1.888.466.3734
Fax: 416.364.1788
Email:


Date Signal Chart Symbol Company Opinion Price
2016-08-03 N/A Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Markets. The market does not like uncertainty or the knowledge of a troublesome event. As long as it is a known, the market can digest it. We have gone through Brexit, which surprised the market completely, and yet it digested it and moved on. In our current situation, we have to look at valuations being historically a little high, but on the other side the US Federal Reserve, in the market’s view, has its back. The Fed wants to maintain orderly markets with a degree of asset inflation, which gives investors comfort. US earnings, so far, seem to be pretty constructive, but the bar has been lowered. This is the 5th quarter in a row that we have seen falling earnings year-over-year, and there is no question that we are in an earnings trough. However, there are signs, especially on the revenue side, we are moving out of that and it is a little more constructive. Expects a better earnings picture over the next year. Technology and telecom has been doing very well. Healthcare has been in a correction phase, but offers good opportunity.


Price:
$0.020
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
_N/A
2016-08-03 PAST TOP PICK Must be logged in to use chart AAPL-Q Apple

(A Top Pick Aug 26/15. Down 2.3%.) After the latest quarter, the obituary has been retracted for now. This is a company and a stock that everyone has an opinion on. It is a highly bifurcated view in that they really love it, or don’t like it at all. You have to remember that this is a company that has been adopted by a great many people as their way of adopting the mobile experience. Thinks that iPhone 7 coming this fall, will be very, very successful. Valuation is extremely attractive, 30% of their market capitalization is in cash, and it is trading at a single digit multiple.


Price:
$105.790
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 BUY Must be logged in to use chart AIG-N American International Group

If you believe that rates will go up, this is a good place to invest. Insurance companies make most of their money on their bond portfolios. This company just reported and had a very strong report by basically increasing the quality of earnings, and recognizing the fact that rates are not rising. Have also cut costs by 11% year-over-year. They’ve been in the program of exiting non-core assets quite effectively. Given their very attractive pricing against their BV, it is a good place to invest.


Price:
$58.100
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 PAST TOP PICK Must be logged in to use chart BA-N Boeing

(A Top Pick Aug 26/15. Up 4.48%.) This has about a half $1 trillion backlog, 5700 airplanes. It is a cash flow story. Their capital expenditure program has really peaked, which means greater and greater free cash flow.


Price:
$131.870
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 PARTIAL BUY Must be logged in to use chart BAC-N Bank of America

He wouldn’t try to time a purchase from a trading standpoint. Take a position and wait for a longer-term secular move in the banks, and you should be well rewarded. 


Price:
$14.480
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
No
2016-08-03 COMMENT Must be logged in to use chart CVS-N CVS Health Corp

Just recently reported, and had a very, very strong quarter. This is a pharmacy that fills a lot of prescriptions. It is also a pharmacy benefits manager, so they are a consolidator and a representative for large groups. There are a lot of things going for a company like this, such as aging demographics, and greater US insurance for people.


Price:
$97.430
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 COMMENT Must be logged in to use chart FB-Q Facebook

This is growing very rapidly. The metrics you want to concentrate on are the average monthly and average daily users, and they continue to rise. This is an advertiser’s dream, and Facebook is taking advantage of that with their mobile applications, and using the bolt-on applications that they have. They are also looking into the future. The future of video and virtual realities. There is a great future for this company.


Price:
$122.510
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 COMMENT Must be logged in to use chart GILD-Q Gilead Sciences Inc.

Has had concerns that the hepatitis C drugs they own, is highly effective, but there are competitors that are taking share. Also, has had price deterioration. A very expensive drug with a $90,000 price tag for a 90-day cure. Groups and the government have exercised a lot of pressure, and have been able to discount that price, which has reduced margins dramatically. It looks cheap, but this is a bit of a trap. Thinks they have developed a fairly good cash hoard. If they made a smart acquisition, he thinks he would be very additive to the company. Would probably not be his 1st choice in the space.


Price:
$80.090
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
No
2016-08-03 TOP PICK Must be logged in to use chart HELE-Q Helen of Troy Ltd.

A developer and distributor of well-known products such as Revlon, Sunbeam, Vidal Sassoon, Dr. Scholl’s, etc. The company has done extremely well, but hit a bit of a hiccup in terms of growth in the last year or 2, but it appears that the growth has resumed. Trading at a mid-teens multiple, but have a very nice free cash flow yield of about 7.5%. This is a good time to buy.


Price:
$95.550
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 COMMENT Must be logged in to use chart JPM-N JP Morgan Chase & Co

He would characterize this as being the senior representative of the US banking sector. It is the healthiest and has the best reputation. If you want to have a position in the US financials, this is certainly a good choice. On the other hand, if you are looking for some valuation recovery, he would look at Citigroup (C-N), Bank of America (BAC-N) or Wells Fargo (WFC-N).


Price:
$64.660
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2016-08-03 PAST TOP PICK Must be logged in to use chart LZB-N La-Z-Boy Inc.

(A Top Pick Aug 26/15. Up 10.69%.) This is really a story about the housing market. There needs to be a lot more household formations to satisfy the population growth. 5 years ago, net margins were about 2%, last year they were 5%, and by the end of the decade he thinks they will be over 7%.


Price:
$29.980
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 DON'T BUY Must be logged in to use chart M-N Macys Inc. (formerly Federated Department Stores)

Wouldn’t invest in this for the long-term, because the headwind of Department stores or brick-and-mortar type retailers is severe. People are getting involved with the ease of online shopping and its cost effectiveness.


Price:
$33.430
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2016-08-03 COMMENT Must be logged in to use chart MRK-N Merck & Company

The difficulty that chemically based pharmaceuticals have had is basically with current legislation. They spend a lot of money developing drugs, and then they go off patent in a few years and they lose that revenue stream. If you look at the financials of all of the majors, basically it is a flat revenue picture, and any cash flow or earnings progress is made through cost cutting. He would prefer the bio side, such as Biogen (BIIB-Q), Celgene (CELG-Q), etc.


Price:
$57.650
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Unknown
2016-08-03 COMMENT Must be logged in to use chart NDAQ-Q Nasdaq Stock Market

He is positive on this. It is a story about volume and technology. They are increasing margins very effectively through using different tools.


Price:
$71.530
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
2016-08-03 TOP PICK Must be logged in to use chart PCLN-Q Priceline.com Inc.

One of the most successful companies on the exchange. It has done extremely well through the years, and continues to do so. An online travel company, and owns booking.com, open table, Kayak. Very, very successful and high growth. Gross bookings rise anywhere from 25% to 30% year-over-year on a quarterly basis. He is looking for about $67 a share in earnings this year, and probably at $80 for next year.


Price:
$1371.140
Subject:
US EQUITIES
Bias:
OPTIMISTIC
Owned:
Yes
Showing 1 to 15 of 1,807 entries
<< < 1 2 3 4 5 > >>

No Comments.


You must be logged in to comment.